Division of Infectious Diseases
-
February 6, 2023
Gut microbiota and lung fibrosis
Microorganisms residing in the gut influence the severity of lung fibrosis in mouse models, suggesting that modifying the gut microbiota may offer therapeutic benefit for patients. -
February 2, 2023
COVID-19 battle begins in the nose
A high upper airway concentration of the virus that causes COVID-19 was associated with changes in gene expression that could impact disease progression, Vanderbilt researchers discovered. -
February 2, 2023
Risk of household flu spread skyrocketed during pandemic
A Vanderbilt study found that the household spread of flu during the 2021-2022 season was more than twice as high as it was prior to the COVID-19 pandemic. -
January 26, 2023
Study to explore COVID’s impact on essential workers
Vanderbilt researchers are inviting non-health care essential workers to participate in a study to better understand how they continue to be impacted by COVID-19. -
January 19, 2023
Emerging Infections Program lands national award for COVID response
Vanderbilt's Emerging Infections Program (EIP) recently received the Toby Merlin Award for Excellence in Emergency Response, presented by the Centers for Disease Control and Prevention (CDC) and the Agency for Toxic Substances and Disease Registry. -
December 21, 2022
Flu season came early, hit hard in Tennessee
Flu season came a month early this year in Tennessee and hit hard, disproportionately affecting children, according to Epidemic Intelligence Service (EIS) data gathered by the Centers for Disease Control and Prevention (CDC), Tennessee Department of Health and Vanderbilt University Medical Center. -
December 15, 2022
Dooley honored by Treatment Action Group
Vanderbilt's Kelly Dooley, MD, PhD, MPH, recently received the Research in Action Award from the Treatment Action Group (TAG).